Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-02-08
2005-02-08
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S114000
Reexamination Certificate
active
06852731
ABSTRACT:
The invention provides a compound of formula I:wherein G, R2, R3, and R4have any of the values defined in the specification, or a pharmaceutically acceptable salt thereof, as well as processes and intermediates useful for preparing such compounds or salts, and methods of preventing or treating a herpesvirus infection using such compounds or salts.
REFERENCES:
patent: 4125611 (1978-11-01), Yamade et al.
patent: 4145418 (1979-03-01), Kuwada et al.
patent: 4767766 (1988-08-01), Baker et al.
patent: 4877793 (1989-10-01), Davies
patent: 4959363 (1990-09-01), Wentland
patent: 5155115 (1992-10-01), Suzuki et al.
patent: 5219864 (1993-06-01), Suzuki et al.
patent: 5352685 (1994-10-01), Maruyama et al.
patent: 5593943 (1997-01-01), Nuebling et al.
patent: 5817819 (1998-10-01), Furuya et al.
patent: 6239142 (2001-05-01), Schnute et al.
patent: 6620810 (2003-09-01), Thorarensen
patent: 4227747 (1994-02-01), None
patent: 0046990 (1982-03-01), None
patent: 0269295 (1988-06-01), None
patent: 0443568 (1991-02-01), None
patent: 0505058 (1992-09-01), None
patent: 0560348 (1993-09-01), None
patent: 2289276 (1995-11-01), None
patent: 46-032198 (1970-09-01), None
patent: 57116077 (1982-07-01), None
patent: 57142985 (1982-09-01), None
patent: 07076586 (1995-03-01), None
patent: 8143573 (1996-06-01), None
patent: 08301849 (1996-11-01), None
patent: 9208496 (1997-08-01), None
patent: WO-9203427 (1992-03-01), None
patent: WO-9528405 (1995-10-01), None
patent: WO-9618616 (1996-06-01), None
patent: WO-9618617 (1996-06-01), None
patent: WO-9740846 (1997-11-01), None
patent: WO-9811073 (1998-03-01), None
patent: WO-9932450 (1999-07-01), None
patent: WO-9962908 (1999-12-01), None
patent: WO-0007595 (2000-02-01), None
patent: WO-0040561 (2000-07-01), None
patent: WO-0040563 (2000-07-01), None
patent: WO-0053610 (2000-09-01), None
patent: WO-0076990 (2000-12-01), None
patent: WO-0158898 (2001-08-01), None
patent: WO-03020729 (2003-03-01), None
Database Crossfire Beilstein,vol. 26, No. 1, Beilstein Institut zur Foerderung der chemischen Wissenschaften,Frankfurt am Main, DE Datebase Accession No. 4321837, (1991).
Database Crossfire Beilstein,vol. 21, Beilstein Institut zur Foerderung der chemischen Wissenschaften,Frankfurt am Main, DE Datebase Accession No. 4381517, (1984).
Blaskiewicz, Peter, “Thienopyridinonecarboxylic Acid Derivatives”,Chemical Abstracts,Abstract of German Patent No. 2,447,477, Abstract No. 85:46627, (Apr. 15, 1976), 1 page.
El-Abadelah, Mustafa M., “Synthesis and Chiroptical Properties of Some N-(2-Chloro-7-cyclopropyl-4.7-dihydro-4-oxo-thieno[2,3-b]pyridine-5-carbonyl) L-α-Amino Esters”,Zeitschrift fur Naturforschung B, A Journal of Chemical Sciences,52 (3), (1997), pp. 419-426.
Elliott, Richard L., et al., “The Preparation of 2-(Heterocyclyl)thieno[3,2-b]pyridine Derivatives”,Tetrahedron,vol. 43, No. 14, (1987), 3295-3302.
Goerlitzer, K., et al., “Gyrase inhibitors; Parts 3.: Synthesis and reactions of ethyl 1,4-dihydro-4-oxo[1]benzothieno[3,2-b]pyridine-3-carboxylate”,Pharmazie,vol. 55, No. 8, (2000), 595-600.
Nishikawa, Yoshinori, et al., “Synthesis and Antiallergic Activity of N-[4-(4-Diphenylmethyl-1-piperazinyl)butyl]-1,4-dihydro-4-oxopyridine-3-carboxamides”,Chem. Pharm. Bull.,vol. 37, No. 5, (1989), 1256-1259.
Patani, G. A., et al., “Bioisosterism: A Rational Approach in Drug Design”,Chemical Reviews,96(8), (1996), 3147-3176.
Revel, L., et al., “MKC-733”,Drugs of the Future,vol. 24, No. 9, (1999), 966-968.
Thornber, C. W., “Isosterism and Molecular Modification in Drug Design”,Chemical Society Reviews,8(4), (1979), 563-580.
Vaillancourt, V. A., et al., “Naphthalene carboxamides as inhibitors of human cytomegalovirus DNA polymerase”,Bioorganic&Medicinal Chemistry Letters,vol. 10, No. 18, (Sep. 2000), 2079-2081.
Anderson David John
Kim Euibong J.
Larsen Scott D.
May Paul
Nieman James A.
Kifle Bruck
Pfizer
Schwegman Lundberg Woessner & Kluth P.A.
LandOfFree
Antiviral compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiviral compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3448463